Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Roivant Sciences Ltd.

ROIV•NASDAQ
Healthcare
Biotechnology
$27.76
$0.61(2.25%)
U.S. Market opens in 16h 15m

Roivant Sciences Ltd. (ROIV) Stock Forecast & Price Predictions

Get the latest Roivant Sciences Ltd. (ROIV) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$26.32
Change↓ $-1.44 (-5.19%)

Quarterly Forecast

Predicted Price$30.81
Change↑ $3.05 (10.99%)

Yearly Forecast

Predicted Price$25.53
Change↓ $-2.23 (-8.03%)

3 Years Forecast

Predicted Price$37.27
Change↑ $9.51 (34.25%)

5 Years Forecast

Predicted Price$49.01
Change↑ $21.25 (76.56%)

7 Years Forecast

Predicted Price$60.20
Change↑ $32.44 (116.86%)

Roivant Sciences Ltd. Stock Forecast Summary

Roivant Sciences Ltd. (ROIV) stock is currently priced at $27.76. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $26.32.

In the long term, ROIV shows a bearish trend. The 2027 forecast points to $25.53 (-8.03% change), while the 2031 forecast suggests $49.01 (76.56% change). Looking 7 years ahead, projections estimate the stock could trade near $60.20, a 116.86% change from today’s price.

Overall Sentiment

Bearish

Short-Term Outlook

Bearish

Long-Term Outlook

Bearish

This mix indicates that Roivant Sciences Ltd. stock is expected to trade sideways over the coming years.

Roivant Sciences Ltd. yearly Price Forecast Chart

Explore the yearly forecast chart for ROIV, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Roivant Sciences Ltd. over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for ROIVForecasting details for ROIV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Roivant Sciences Ltd. Stock Forecast 2026

The forecast for Roivant Sciences Ltd. (ROIV) in 2026 suggests a price of $25.53, representing a -8.03% move from today’s price.

Average Target: $25.53

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Roivant Sciences Ltd. Stock Forecast 2030

By 2030, Meyka AI projects ROIV could trade near $49.01, showing a potential 76.56% compared to current levels.

Average Target: $49.01

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Roivant Sciences Ltd..

Roivant Sciences Ltd. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for ROIV points to a price around $60.20, which is a projected 116.86% move from today’s level.

Average Target: $60.20

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • Roivant Sciences Ltd.’s ability to maintain market leadership.

Frequently Asked Questions